Advertisement

Topics

Eisai: U.K. NICE Recommends Anticancer Agent Lenvima as Treatment for Thyroid Cancer

19:04 EST 15 Feb 2018 | FinanzNachrichten

Following the issue of the FAD by NICE, lenvatinib will be eligible for reimbursement for this indication via the National Health Service in England (NHS England).TOKYO, Feb 16, 2018 - (JCN Newswir...

Related Biotechnology, Pharmaceutical and Healthcare News

Original Article: Eisai: U.K. NICE Recommends Anticancer Agent Lenvima as Treatment for Thyroid Cancer

NEXT ARTICLE

More From BioPortfolio on "Eisai: U.K. NICE Recommends Anticancer Agent Lenvima as Treatment for Thyroid Cancer"

Advertisement

Quick Links
Advanced Search | Login | Subscribe | RSS

Quick Search
Advertisement
Advertisement

 

Relevant Topic

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...


News Quicklinks

Search Biotech, Medical and Healthcare News

Popular Biotech, Medical and Healthcare News

Biotech News by Article Type

BioPortfolio Bloggers

Publishing Your News on BioPortfolio

Recent Visitor News Searches

BioPortfolio Limited Social Media
Publish Content Agreements
Tools Help

HON Code certificate This site complies with the HONcode standard for trustworthy health information:
Verify here.

The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored BioPortfolio Limited with offices at Stafford House, 10 Prince of Wales Road, Dorchester, DT1 1PW, England. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact BioPortfolio.
All rights reserved. All other trademarks recognized. Copyright © 1997-2018 BioPortfolio Limited. Site developed by Alacrify Ltd.